Form D · Other Technology
Novome Biotechnologies, Inc.
Daly City, CA · CIK 0001694013
Offering snapshot reported Jan 10, 2017 · SEC filing
- Reported sold
- $536K Offering amount: $700K
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 29, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 10, 2017 | Initial | $535,623 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 05, 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-278006
Source: Form D, filed Jan 10, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William De Loache | Director |
| Samuel Smits | Director |
| Elizabeth Stanley | Director |
| Weston Whitaker | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
15 Westmont Drive
Daly City, CA, 94015
Daly City, CA, 94015